SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's gets USFDA’s approval for ANDA VeraRing

11 Dec 2021 Evaluate

Dr. Reddy's Laboratories has received approval from the U.S. Food and Drug Administration (USFDA) for ANDA 207577 (VeraRing). The company is evaluating further steps in relation to this product.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1357.70 -18.60 (-1.35%)
30-Jun-2026 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1875.90
Dr. Reddys Labs. 1357.70
Cipla 1466.95
Zydus Lifesciences 1113.70
Lupin 2417.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: